DETECTION OF AUTOANTIBODIES RECOGNIZING CANCERRETINA ANTIGEN RECOVERIN IN BLOOD OF PATIENTS WITH NON-INVASIVE FOLLICULAR THYROID NEOPLASMS WITH PAPILLARY-LIKE NUCLEAR FEATURES (NIFTP)

Autoantibodies recognizing the cancer-retina autoantigen called recoverin (RCVRN-AutoAb) may serve as a highly specific biomarker of cancer-associated retinopathy. However, they may also be found in some cancer patients without clinical evidence of retinopathy. In the present study, dot-ELISA and Western blot assays were used to demonstrate the presence of circulating RCVRN-AutoAb in 4/7 (57%) of patients with recently recognized pathological entity, non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP); other thyroid tumors represented by follicular adenomas, and classical and follicular variants of papillary thyroid carcinomas, demonstrated low frequencies of RCVRN-AutoAb (0/15, 1/20 (5%) and 1/15 (7%), respectively), with no significant differences from healthy individuals (0/15). Our data implicate the circulating RCVRN-AutoAb as a potential biomarker of NIFTP capable of discrimination of this novel pathological entity from other thyroid tumors.

1. Abrosimov A.Yu. Encapsulated follicular thyroid tumors of uncertain malignant potential in the new international histological classification. Klinicheskaya i eksperimentalnaya tireoidologiya = Clinical and Experimental Thyroidology, 2018, Vol. 13, no. 4, pp. 9-15. (In Russ.)

2. Lanshchakov K.V., Belousov P.V., Vanushko V.E., Abrosimov A. Yu., Kuprash D.V., Kuznetsov N.S. Autoantibody profiling of benign and malignant thyroid tumors and design of a prototype diagnostic array. Endokrinnaya khirurgiya = Endocrine Surgery, 2012, Vol. 2, pp. 15-20. (In Russ.)

3. Bazhin A.V., Schadendorf D., Philippov P.P., Eichmüller S.B. Recoverin as a cancer-retina antigen. Cancer Immunol. Immunother., 2007, Vol. 56, no. 1, pp. 110-116.

4. Belousov P.V., Bogolyubova A.V., Kim Y.S., Abrosimov A.Y., Kopylov A.T., Tvardovskiy A.A., Lanshchakov K.V., Sazykin A.Y., Dvinskikh N.Y., Bobrovskaya Y.I., Selivanova L.S., Shilov E.S., Schwartz A.M., Shebzukhov Y.V., Severskaia N.V., Vanushko V.E., Moshkovskii S.A., Nedospasov S.A., Kuprash D.V. Serum immunoproteomics combined with pathological reassessment of surgical specimens identifies TCP-1ζ autoantibody as a potential biomarker in thyroid neoplasia. J. Clin. Endocrinol. Metab., 2015, Vol. 100, no. 9, pp. E1206-E1215.

5. Dizhoor A.M., Ray S., Kumar S., Niemi G., Spencer M., Brolley D., Walsh K.A., Philipov P.P., Hurley J.B., Stryer L. Recoverin: a calcium sensitive activator of retinal rod guanylate cyclase. Science, 1991, Vol. 251, no. 4996, pp. 915-918.

6. Golovastova M.O., Tsoy L.V., Bocharnikova A.V., Korolev D.O., Gancharova O.S., Alekseeva E.A., Kuznetsova E.B., Savvateeva L.V., Skorikova E.E., Strelnikov V.V., Varshavsky V.A., Vinarov A.Z., Nikolenko V.N., Glybochko P.V., Zernii E.Y., Zamyatnin A.A. Jr, Bazhin A.V., Philippov P.P. The cancer-retina antigen recoverin as a potential biomarker for renal tumors. Tumour Biol., 2016, Vol. 37, no. 7, pp. 9899-9907.

7. Lloyd R.V., Osamura R.Y., Klöppel G., Rosai J. WHO Classification of Tumours of Endocrine Organs. 4th ed. Lyon: IARC Press, 2017.

8. Machida S., Ohguro H., Ishida K., Suzuki M., Kawagishi K. Recoverin-associated retinopathy secondary to Warthin tumor of parotid gland. Doc. Ophthalmol., 2014, Vol. 129, no. 2, pp. 123-128.

9. Nikiforov Y.E., Seethala R.R., Tallini G., Baloch Z.W., Basolo F., Thompson L.D.R., Barletta J.A., Wenig B.M., Al Ghuzlan A., Kakudo K., Giordano T.J., Alves V.A., Khanafshar E., Asa S.L., El-Naggar A.K., Gooding W.E., Hodak S.P., Lloyd R.V., Maytal G., Mete O., Nikiforova M.N., Nosé V., Papotti M., Poller D.N., Sadow P.M., Tischler A.S., Tuttle R.M., Wall K.B., LiVolsi V.A., Randolph G.W., Ghossein R.A. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: A paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol., 2016, Vol. 2, no. 8, pp. 1023-1029.

10. Philippov P.P., Zernii E.Y. Recoverin. Encyclopedia of Signaling Molecules. New York: Springer New York, 2016, pp. 1-9.

11. Savchenko M.S., Goncharskaia M.A., Skorikova E.E., Eichmüller S.B., Kushlinsky N.E., Bazhin A.V., Philippov P.P. Autoantibodies against the Ca(2+)-binding protein recoverin in blood sera of patients with various oncological diseases. Oncol. Lett., 2012, Vol. 3, no. 2, pp. 377-382.

12. Tanaka A., Takase H., Adamus G., Mochizuki M. Cancer-associated retinopathy caused by benign thymoma. Br. J. Ophthalmol., 2010, Vol. 94, no. 4, pp. 526-528.